• AFM Téléthon
  • Biotherapies Institute
  • I-Stem
  • Institute of Myology
  • Genethon

Institut Des Biothérapies

  • English
  • Français
  • About us
  • Skills
  • Biotherapies
  • News
Cure through innovation
More than 530 researchers, engineers and medical experts
25 000 m2 of laboratory space in Paris and Evry
Making treatments available to patients
Coronavirus : L’ AFM-Téléthon pleinement mobilisée pour vous informer
   

Breaking news

  • 20 April 2021  Duchenne Muscular Dystrophy : First child dosed in Clinical Trial of Investigational Gene therapy
  • 2 June 2020  A Genethon team has succeeded in inhibiting the immune response linked to AAV
  • 25 June 2019  CRISPR-Cas9 : First in vivo proof-of-concept in Steinert’s myotonic dystrophy, a neuromuscular disease
  • 4 June 2019  The first FDA-approved gene therapy for a neuromuscular disease in the United States is a wonderful hope for patients, also a key challenge for France
  • 29 May 2019  Gene therapy : Towards a clinical trial for gamma-sarcoglycanopathy, limb-girdle muscular dystrophy
  • 25 February 2019  Treatment of X-CGD : positive results of the gene therapy initiated by Genethon
All the latest news

 
  • Contact us